First, the FDAs resolution of the semaglutide and tirzepatide shortages in mid-2024 ended the broad compounding allowance under section 503A, narrowing the legal path for compounded versions to patients with documented medical need (specific dose unavailable, sensitivity to a commercial inactive ingredient)
Best sources oats, lentils, chia seeds, berries, broccoli, pears
7 MGH subsequently announced that its 2025 Warren Triennial Prize would be given to Habener, Drucker, Holst, and Mojsov [61]
Elevated GLP-1 levels in AKI may reflect a protective or injury-related response, potentially driven by both systemic inflammation and reduced renal clearance